Progression of liver fibrosis in women infected with hepatitis C: Long-term benefit of estrogen exposure

被引：3
|
作者：
Campbell, M
Yang, YX
Reddy, KR
机构：
[1] Hosp Univ Penn, Div Gastroenterol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Clin Ctr Epidemiol & Biostat, Philadelphia, PA 19104 USA
来源：
HEPATOLOGY | 2005年 / 41卷 / 04期
关键词：
D O I：
10.1002/hep.20611
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：939 / 939
页数：1
相关论文
共 50 条
  • [41] Long-term survival following liver transplantation in hepatitis C patients.
    Graziadei, IW
    Nachbauer, K
    Koenigsrainer, A
    Margreiter, R
    Vogel, W
    HEPATOLOGY, 2000, 32 (04) : 262A - 262A
  • [42] Long-term outcome of hepatitis C virus infection after liver transplantation
    Boker, KHW
    Dalley, G
    Bahr, MJ
    Maschek, H
    Tillmann, HL
    Trautwein, C
    Oldhaver, K
    Bode, U
    Pichlmayr, R
    Manns, MP
    HEPATOLOGY, 1997, 25 (01) : 203 - 210
  • [43] Long-term antiviral treatment for recurrent hepatitis C after liver transplantation
    Bertuzzo, Valentina Rosa
    Cescon, Matteo
    Morelli, Maria Cristina
    Di Gioia, Paolo
    Tame, Mariarosa
    Lorenzini, Stefania
    Andreone, Pietro
    Ercolani, Giorgio
    Del Gaudio, Massimo
    Ravaioli, Matteo
    Cucchetti, Alessandro
    Dazzi, Alessandro
    D'Errico-Grigioni, Antonietta
    Pinna, Antonio Daniele
    DIGESTIVE AND LIVER DISEASE, 2012, 44 (10) : 861 - 867
  • [44] Long-term ribavirin therapy for recurrent hepatitis C after liver transplantation
    Aljumah, AA
    Cattral, MS
    Greig, PD
    Wanless, IR
    Krajden, M
    Hemming, AW
    Lilly, LB
    Levy, GA
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 514 - 514
  • [45] Clerance of hepatitis C viremia improves long-term survival in liver recipients with recurrent hepatitis C.
    Kornberg, Arno
    Kuepper, Bernadette
    Baerthel, Erik
    Thrum, Katharina
    Wilberg, Jens
    Hommann, Merten
    Settmacher, Utz
    LIVER TRANSPLANTATION, 2007, 13 (06) : S168 - S168
  • [46] A cirrhosis risk score identifies those chronic hepatitis C infected patients presenting with no liver fibrosis that are at high risk for fibrosis progression
    Young, Bradford
    Gerotto, Martina
    Morcolongo, Moira
    Dal Pero, Francesca
    Lagier, Robert
    Rowland, Charles
    Sebastiani, Giodo
    Alberti, Alfredo
    Alameda, Celera
    HEPATOLOGY, 2007, 46 (04) : 442A - 443A
  • [47] LONG-TERM FIBROSIS AND VIRAL LEVEL PROGRESSION AMONG TREATED AND UNTREATED PATIENTS WITH CHRONIC HEPATITIS B
    Li, J.
    Gordon, S.
    Rupp, L.
    Zhang, T.
    Boscarino, J.
    Trinacty, C.
    Schmidt, M.
    Moorman, A.
    Holmberg, S.
    Lu, M.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S371 - S371
  • [48] ANTICOAGULATION FOR LIVER FIBROSIS: A PILOT STUDY IN HEPATITIS C INFECTED PATIENTS
    Dhar, Ameet
    Anstee, Quentin M.
    Cobbold, Jeremy F.
    Stove, Julie A.
    Martinelli, Ana L.
    Taylor-Robinson, Simon D.
    Thursz, Mark R.
    HEPATOLOGY, 2010, 52 (04) : 1133A - 1133A
  • [49] Long term phlebotomy suppresses the progression of liver histological staging in patients with chronic hepatitis C
    Yano, M
    Yoshioka, K
    Takikawa, T
    Hayashi, H
    HEPATOLOGY, 1998, 28 (04) : 474A - 474A
  • [50] Short- and long-term outcome of orthotopic liver transplantation using hepatitis C virus-infected allografts.
    Vasta, F
    Fung, JJ
    Eghtesad, B
    Blisard, D
    Demetris, AJ
    Cacciarelli, TV
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 517 - 517
12345